{"entity":{"type":"insider","cik":"0001937482","url":"/insider/0001937482","json_url":"/insider/0001937482.json","name":"Yu Yong","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":19,"first":"2023-08-22","last":"2026-08-04","span_basis":"filed_date"},"name_variants":[{"name":"Yu Yong","source":"filing","n_filings":19,"first_seen":"2023-08-22","last_seen":"2026-08-04"}],"transactions":[{"id":5871477,"accession":"0001493152-26-036077","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-26-036077","line_url":"/filing/0001493152-26-036077#line-1","is_derivative":false,"issuer_cik":"0001231457","issuer_name":"GENELUX Corp","issuer_ticker":"GNLX","issuer_name_source":null,"issuer_url":"/issuer/0001231457","owner_cik":"0001937482","owner_name":"Yu Yong","owner_display_name":"Yu Yong","owner_url":"/insider/0001937482","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":653.0,"shares_display":"653","price_per_share":2.9434,"price_display":"2.94","price_state":"stated","total_value":1922.0402,"total_display":"1,922.04","total_whole":"1,922","shares_owned_after":268371.0,"shares_owned_after_display":"268,371","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-04","filed_date":"2026-08-04","scope":"insider"},{"id":5765694,"accession":"0001493152-26-022567","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-26-022567","line_url":"/filing/0001493152-26-022567#line-1","is_derivative":false,"issuer_cik":"0001231457","issuer_name":"GENELUX Corp","issuer_ticker":"GNLX","issuer_name_source":null,"issuer_url":"/issuer/0001231457","owner_cik":"0001937482","owner_name":"Yu Yong","owner_display_name":"Yu Yong","owner_url":"/insider/0001937482","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":605.0,"shares_display":"605","price_per_share":2.9726,"price_display":"2.97","price_state":"stated","total_value":1798.423,"total_display":"1,798.42","total_whole":"1,798","shares_owned_after":149706.0,"shares_owned_after_display":"149,706","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-11","filed_date":"2026-05-12","scope":"insider"},{"id":5881477,"accession":"0001493152-26-012970","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-26-012970","line_url":"/filing/0001493152-26-012970#line-1","is_derivative":false,"issuer_cik":"0001231457","issuer_name":"GENELUX Corp","issuer_ticker":"GNLX","issuer_name_source":null,"issuer_url":"/issuer/0001231457","owner_cik":"0001937482","owner_name":"Yu Yong","owner_display_name":"Yu Yong","owner_url":"/insider/0001937482","role":"Officer (SVP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":906.0,"shares_display":"906","price_per_share":2.42,"price_display":"2.42","price_state":"stated","total_value":2192.52,"total_display":"2,192.52","total_whole":"2,193","shares_owned_after":144938.0,"shares_owned_after_display":"144,938","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-24","filed_date":"2026-03-26","scope":"insider"},{"id":5090758,"accession":"0001493152-25-027338","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-25-027338","line_url":"/filing/0001493152-25-027338#line-2","is_derivative":false,"issuer_cik":"0001231457","issuer_name":"GENELUX Corp","issuer_ticker":"GNLX","issuer_name_source":null,"issuer_url":"/issuer/0001231457","owner_cik":"0001937482","owner_name":"Yu Yong","owner_display_name":"Yu Yong","owner_url":"/insider/0001937482","role":"Officer (SVP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":973.0,"shares_display":"973","price_per_share":5.3694,"price_display":"5.37","price_state":"stated","total_value":5224.4262,"total_display":"5,224.43","total_whole":"5,224","shares_owned_after":145844.0,"shares_owned_after_display":"145,844","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-12-11","scope":"insider"},{"id":5090753,"accession":"0001493152-25-027338","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-25-027338","line_url":"/filing/0001493152-25-027338#line-1","is_derivative":false,"issuer_cik":"0001231457","issuer_name":"GENELUX Corp","issuer_ticker":"GNLX","issuer_name_source":null,"issuer_url":"/issuer/0001231457","owner_cik":"0001937482","owner_name":"Yu Yong","owner_display_name":"Yu Yong","owner_url":"/insider/0001937482","role":"Officer (SVP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (SVP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3219.0,"shares_display":"3,219","price_per_share":3.3574,"price_display":"3.36","price_state":"stated","total_value":10807.4706,"total_display":"10,807.47","total_whole":"10,807","shares_owned_after":146817.0,"shares_owned_after_display":"146,817","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-21","filed_date":"2025-12-11","scope":"insider"},{"id":5039417,"accession":"0001415889-25-012807","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-012807","line_url":"/filing/0001415889-25-012807#line-1","is_derivative":false,"issuer_cik":"0001231457","issuer_name":"GENELUX Corp","issuer_ticker":"GNLX","issuer_name_source":null,"issuer_url":"/issuer/0001231457","owner_cik":"0001937482","owner_name":"Yu Yong","owner_display_name":"Yu Yong","owner_url":"/insider/0001937482","role":"Officer (VP, Clinical Trial Operations)","role_mark":"O","role_mark_label":"Officer (VP, Clinical Trial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Clinical Trial Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5579.0,"shares_display":"5,579","price_per_share":2.92,"price_display":"2.92","price_state":"stated","total_value":16290.68,"total_display":"16,290.68","total_whole":"16,291","shares_owned_after":47640.0,"shares_owned_after_display":"47,640","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-12","filed_date":"2025-05-13","scope":"insider"},{"id":2190216,"accession":"0001415889-24-019343","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-019343","line_url":"/filing/0001415889-24-019343#line-3","is_derivative":false,"issuer_cik":"0001231457","issuer_name":"GENELUX Corp","issuer_ticker":"GNLX","issuer_name_source":null,"issuer_url":"/issuer/0001231457","owner_cik":"0001937482","owner_name":"Yu Yong","owner_display_name":"Yu Yong","owner_url":"/insider/0001937482","role":"Officer (VP, Clinical Trial Operations)","role_mark":"O","role_mark_label":"Officer (VP, Clinical Trial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Clinical Trial Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6849.0,"shares_display":"6,849","price_per_share":2.12,"price_display":"2.12","price_state":"stated","total_value":14519.88,"total_display":"14,519.88","total_whole":"14,520","shares_owned_after":10869.0,"shares_owned_after_display":"10,869","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-24","filed_date":"2024-07-08","scope":"insider"},{"id":2391590,"accession":"0001415889-24-016101","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-016101","line_url":"/filing/0001415889-24-016101#line-1","is_derivative":false,"issuer_cik":"0001231457","issuer_name":"GENELUX Corp","issuer_ticker":"GNLX","issuer_name_source":null,"issuer_url":"/issuer/0001231457","owner_cik":"0001937482","owner_name":"Yu Yong","owner_display_name":"Yu Yong","owner_url":"/insider/0001937482","role":"Officer (VP, Clinical Trial Operations)","role_mark":"O","role_mark_label":"Officer (VP, Clinical Trial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Clinical Trial Operations","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-29","filed_date":"2024-06-07","scope":"insider"},{"id":8441927,"accession":"0001209191-23-058954","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-058954","line_url":"/filing/0001209191-23-058954","is_derivative":false,"issuer_cik":"0001231457","issuer_name":"GENELUX Corp","issuer_ticker":"GNLX","issuer_name_source":null,"issuer_url":"/issuer/0001231457","owner_cik":"0001937482","owner_name":"Yu Yong","owner_display_name":"Yu Yong","owner_url":"/insider/0001937482","role":"Officer (VP, Clinical Trial Operations)","role_mark":"O","role_mark_label":"Officer (VP, Clinical Trial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Clinical Trial Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32535.0,"shares_display":"32,535","price_per_share":13.160590812970646,"price_display":"13.16","price_state":"stated","total_value":428179.8221,"total_display":"428,179.82","total_whole":"428,180","shares_owned_after":5803.0,"shares_owned_after_display":"5,803","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-15","filed_date":"2023-12-18","scope":"insider","n_lines":2},{"id":8079572,"accession":"0001209191-23-057975","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-057975","line_url":"/filing/0001209191-23-057975#line-1","is_derivative":false,"issuer_cik":"0001231457","issuer_name":"GENELUX Corp","issuer_ticker":"GNLX","issuer_name_source":null,"issuer_url":"/issuer/0001231457","owner_cik":"0001937482","owner_name":"Yu Yong","owner_display_name":"Yu Yong","owner_url":"/insider/0001937482","role":"Officer (VP, Clinical Trial Operations)","role_mark":"O","role_mark_label":"Officer (VP, Clinical Trial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Clinical Trial Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36800.0,"shares_display":"36,800","price_per_share":11.8477,"price_display":"11.85","price_state":"stated","total_value":435995.36,"total_display":"435,995.36","total_whole":"435,995","shares_owned_after":32535.0,"shares_owned_after_display":"32,535","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-07","filed_date":"2023-12-08","scope":"insider"},{"id":8255636,"accession":"0001209191-23-056455","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-056455","line_url":"/filing/0001209191-23-056455#line-1","is_derivative":false,"issuer_cik":"0001231457","issuer_name":"GENELUX Corp","issuer_ticker":"GNLX","issuer_name_source":null,"issuer_url":"/issuer/0001231457","owner_cik":"0001937482","owner_name":"Yu Yong","owner_display_name":"Yu Yong","owner_url":"/insider/0001937482","role":"Officer (VP, Clinical Trial Operations)","role_mark":"O","role_mark_label":"Officer (VP, Clinical Trial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Clinical Trial Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18665.0,"shares_display":"18,665","price_per_share":10.2628,"price_display":"10.26","price_state":"stated","total_value":191555.162,"total_display":"191,555.16","total_whole":"191,555","shares_owned_after":69335.0,"shares_owned_after_display":"69,335","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-21","filed_date":"2023-11-22","scope":"insider"},{"id":7955370,"accession":"0001209191-23-056237","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-056237","line_url":"/filing/0001209191-23-056237#line-2","is_derivative":false,"issuer_cik":"0001231457","issuer_name":"GENELUX Corp","issuer_ticker":"GNLX","issuer_name_source":null,"issuer_url":"/issuer/0001231457","owner_cik":"0001937482","owner_name":"Yu Yong","owner_display_name":"Yu Yong","owner_url":"/insider/0001937482","role":"Officer (VP, Clinical Trial Operations)","role_mark":"O","role_mark_label":"Officer (VP, Clinical Trial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Clinical Trial Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14594.0,"shares_display":"14,594","price_per_share":11.2554,"price_display":"11.26","price_state":"stated","total_value":164261.3076,"total_display":"164,261.31","total_whole":"164,261","shares_owned_after":88000.0,"shares_owned_after_display":"88,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-20","filed_date":"2023-11-21","scope":"insider"},{"id":7955366,"accession":"0001209191-23-056237","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-056237","line_url":"/filing/0001209191-23-056237#line-1","is_derivative":false,"issuer_cik":"0001231457","issuer_name":"GENELUX Corp","issuer_ticker":"GNLX","issuer_name_source":null,"issuer_url":"/issuer/0001231457","owner_cik":"0001937482","owner_name":"Yu Yong","owner_display_name":"Yu Yong","owner_url":"/insider/0001937482","role":"Officer (VP, Clinical Trial Operations)","role_mark":"O","role_mark_label":"Officer (VP, Clinical Trial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Clinical Trial Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3541.0,"shares_display":"3,541","price_per_share":13.0386,"price_display":"13.04","price_state":"stated","total_value":46169.6826,"total_display":"46,169.68","total_whole":"46,170","shares_owned_after":102594.0,"shares_owned_after_display":"102,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-17","filed_date":"2023-11-21","scope":"insider"},{"id":8044356,"accession":"0001209191-23-053554","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-053554","line_url":"/filing/0001209191-23-053554#line-2","is_derivative":false,"issuer_cik":"0001231457","issuer_name":"GENELUX Corp","issuer_ticker":"GNLX","issuer_name_source":null,"issuer_url":"/issuer/0001231457","owner_cik":"0001937482","owner_name":"Yu Yong","owner_display_name":"Yu Yong","owner_url":"/insider/0001937482","role":"Officer (VP, Clinical Trial Operations)","role_mark":"O","role_mark_label":"Officer (VP, Clinical Trial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Clinical Trial Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5200.0,"shares_display":"5,200","price_per_share":19.106,"price_display":"19.11","price_state":"stated","total_value":99351.2,"total_display":"99,351.20","total_whole":"99,351","shares_owned_after":106135.0,"shares_owned_after_display":"106,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-24","filed_date":"2023-10-25","scope":"insider"},{"id":7955061,"accession":"0001209191-23-052621","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-052621","line_url":"/filing/0001209191-23-052621","is_derivative":false,"issuer_cik":"0001231457","issuer_name":"GENELUX Corp","issuer_ticker":"GNLX","issuer_name_source":null,"issuer_url":"/issuer/0001231457","owner_cik":"0001937482","owner_name":"Yu Yong","owner_display_name":"Yu Yong","owner_url":"/insider/0001937482","role":"Officer (VP, Clinical Trial Operations)","role_mark":"O","role_mark_label":"Officer (VP, Clinical Trial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Clinical Trial Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5200.0,"shares_display":"5,200","price_per_share":22.01190769230769,"price_display":"22.01","price_state":"stated","total_value":114461.92,"total_display":"114,461.92","total_whole":"114,462","shares_owned_after":106535.0,"shares_owned_after_display":"106,535","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-10","filed_date":"2023-10-11","scope":"insider","n_lines":2},{"id":8116868,"accession":"0001209191-23-050643","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-050643","line_url":"/filing/0001209191-23-050643","is_derivative":false,"issuer_cik":"0001231457","issuer_name":"GENELUX Corp","issuer_ticker":"GNLX","issuer_name_source":null,"issuer_url":"/issuer/0001231457","owner_cik":"0001937482","owner_name":"Yu Yong","owner_display_name":"Yu Yong","owner_url":"/insider/0001937482","role":"Officer (VP, Clinical Trial Operations)","role_mark":"O","role_mark_label":"Officer (VP, Clinical Trial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Clinical Trial Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5200.0,"shares_display":"5,200","price_per_share":23.56304903846154,"price_display":"23.56","price_state":"stated","total_value":122527.855,"total_display":"122,527.86","total_whole":"122,528","shares_owned_after":106135.0,"shares_owned_after_display":"106,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-26","filed_date":"2023-09-27","scope":"insider","n_lines":3},{"id":8405244,"accession":"0001209191-23-050282","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-050282","line_url":"/filing/0001209191-23-050282#line-2","is_derivative":false,"issuer_cik":"0001231457","issuer_name":"GENELUX Corp","issuer_ticker":"GNLX","issuer_name_source":null,"issuer_url":"/issuer/0001231457","owner_cik":"0001937482","owner_name":"Yu Yong","owner_display_name":"Yu Yong","owner_url":"/insider/0001937482","role":"Officer (VP, Clinical Trial Operations)","role_mark":"O","role_mark_label":"Officer (VP, Clinical Trial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Clinical Trial Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":27.9643,"price_display":"27.96","price_state":"stated","total_value":167785.8,"total_display":"167,785.80","total_whole":"167,786","shares_owned_after":106135.0,"shares_owned_after_display":"106,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-20","filed_date":"2023-09-21","scope":"insider"},{"id":7973478,"accession":"0001209191-23-049841","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-049841","line_url":"/filing/0001209191-23-049841","is_derivative":false,"issuer_cik":"0001231457","issuer_name":"GENELUX Corp","issuer_ticker":"GNLX","issuer_name_source":null,"issuer_url":"/issuer/0001231457","owner_cik":"0001937482","owner_name":"Yu Yong","owner_display_name":"Yu Yong","owner_url":"/insider/0001937482","role":"Officer (VP, Clinical Trial Operations)","role_mark":"O","role_mark_label":"Officer (VP, Clinical Trial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Clinical Trial Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10400.0,"shares_display":"10,400","price_per_share":21.88752235576923,"price_display":"21.89","price_state":"stated","total_value":227630.2325,"total_display":"227,630.23","total_whole":"227,630","shares_owned_after":110810.0,"shares_owned_after_display":"110,810","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-15","filed_date":"2023-09-18","scope":"insider","n_lines":2},{"id":7999453,"accession":"0001209191-23-049673","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-049673","line_url":"/filing/0001209191-23-049673#line-1","is_derivative":false,"issuer_cik":"0001231457","issuer_name":"GENELUX Corp","issuer_ticker":"GNLX","issuer_name_source":null,"issuer_url":"/issuer/0001231457","owner_cik":"0001937482","owner_name":"Yu Yong","owner_display_name":"Yu Yong","owner_url":"/insider/0001937482","role":"Officer (VP, Clinical Trial Operations)","role_mark":"O","role_mark_label":"Officer (VP, Clinical Trial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Clinical Trial Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29800.0,"shares_display":"29,800","price_per_share":21.1385,"price_display":"21.14","price_state":"stated","total_value":629927.3,"total_display":"629,927.30","total_whole":"629,927","shares_owned_after":106135.0,"shares_owned_after_display":"106,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-13","filed_date":"2023-09-15","scope":"insider"},{"id":8222197,"accession":"0001209191-23-047784","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-047784","line_url":"/filing/0001209191-23-047784#line-1","is_derivative":false,"issuer_cik":"0001231457","issuer_name":"GENELUX Corp","issuer_ticker":"GNLX","issuer_name_source":null,"issuer_url":"/issuer/0001231457","owner_cik":"0001937482","owner_name":"Yu Yong","owner_display_name":"Yu Yong","owner_url":"/insider/0001937482","role":"Officer (VP, Clinical Trial Operations)","role_mark":"O","role_mark_label":"Officer (VP, Clinical Trial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Clinical Trial Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19800.0,"shares_display":"19,800","price_per_share":24.7,"price_display":"24.70","price_state":"stated","total_value":489060.0,"total_display":"489,060.00","total_whole":"489,060","shares_owned_after":135935.0,"shares_owned_after_display":"135,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-30","filed_date":"2023-08-30","scope":"insider"},{"id":7973273,"accession":"0001209191-23-046879","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-046879","line_url":"/filing/0001209191-23-046879#line-1","is_derivative":false,"issuer_cik":"0001231457","issuer_name":"GENELUX Corp","issuer_ticker":"GNLX","issuer_name_source":null,"issuer_url":"/issuer/0001231457","owner_cik":"0001937482","owner_name":"Yu Yong","owner_display_name":"Yu Yong","owner_url":"/insider/0001937482","role":"Officer (VP, Clinical Trial Operations)","role_mark":"O","role_mark_label":"Officer (VP, Clinical Trial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Clinical Trial Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3265.0,"shares_display":"3,265","price_per_share":23.73,"price_display":"23.73","price_state":"stated","total_value":77478.45,"total_display":"77,478.45","total_whole":"77,478","shares_owned_after":155735.0,"shares_owned_after_display":"155,735","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-18","filed_date":"2023-08-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":26,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":25,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":26},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001231457","name":"GENELUX Corp","url":"/issuer/0001231457","role":"Officer (Chief Scientific Officer)","n_filings":19,"first_seen":"2023-08-22","last_seen":"2026-08-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001937482","retrieved_at":"2026-08-22T18:41:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}